NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:28
NeurAxis EPS Diluted (Quarterly) : -0.1879 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1879 |
| March 31, 2026 | -0.1782 |
| December 31, 2025 | -0.1787 |
| September 30, 2025 | -0.235 |
| June 30, 2025 | -0.2227 |
| March 31, 2025 | -0.3339 |
| December 31, 2024 | -0.2309 |
| September 30, 2024 | -0.251 |
| June 30, 2024 | -0.4216 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.3237 |
| December 31, 2023 | -0.8163 |
| September 30, 2023 | -2.379 |
| June 30, 2023 | -1.236 |
| March 31, 2023 | -0.3847 |
| December 31, 2022 | -0.0336 |
| June 30, 2022 | -0.8696 |
| March 31, 2022 | -0.1185 |
| December 31, 2021 | -0.1703 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5294 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.0348 |
| AtriCure, Inc. | 0.0816 |
| Baxter International, Inc. | 0.5654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.086M |
| Revenue (Quarterly) | 1.929M |
| Total Expenses (Quarterly) | 4.014M |
| Enterprise Value | 68.14M |
| Gross Profit Margin (Quarterly) | 85.87% |
| Profit Margin (Quarterly) | -108.1% |
| Earnings Yield | -12.56% |
| Normalized Earnings Yield | -12.52 |